- Market Access StrategySince 2008, KAMEDIS CONSEILS with its dual expertise in market access and health economic, is a partner supporting its customers in the market access strategy of their products with the various authorities ( ANSM , HAS, CEPS , DGOS ... ) , in many therapeutic areas.It is the development of a true relationship with the authorities on all clinical development of products but also with clini- cal experts, leading to a personalized strategy for each client.- Pricing and reimbursement, early accessWriting of reimbursement dossiers ( drugs, medical devices , medical procedures)Writing of pricing dossiersEarly market access strategies: ATU , access to innovation (PHRC , PRME , innovation package)Interviews with authorities ( ANSM ; CT, CNEDiMTS and CEESP of HAS; CEPS; DGOS; CNAMTS) : early meetings, negotiations and auditionsBoard of Experts- Health EconomicsDevelopment of models: budget impact, cost-e ectiveness or cost utility, cost-minimization, cost-bene t Writing of cost-e ectiveness dossiersDevelopment of health-economic argumentsWriting of CSIS dossiers (Strategic Council of Health Industries)- Observational studiesImplementation , monitoring and analysis of post-marketing , pharmaco-epidemiology and health economics studiesWriting of clinical study reports- Our valuesOverview of the market access strategy in France ; Personalized partnership with pharmaceutical compa- nies in their market access strategy ; Key player with authorities and experts